Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Ibudilast + Temozolomide |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Ibudilast | AV411|MN166|MN-166 | Ibudilast (MN-166) is a small molecule inhibitor of macrophage migration inhibitory factor (MIF), which may decrease tumor cell proliferation and cell migration (PMID: 30814573, PMID: 20534506). | ||
| Temozolomide | Temodar | Methazolastone|TMZ | Chemotherapy - Alkylating 18 | Temodar (temozolomide) is a dacarbazine analog and cytotoxic alkylating agent (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03782415 | Phase Ib/II | Temozolomide Ibudilast + Temozolomide | Study to Evaluate Ibudilast and TMZ Combo Treatment in Recurrent GBM | Completed | USA | 0 |